World's Best Scientists 2026 revealed!
Steven E. Schild

Steven E. Schild

D-Index & Metrics

Medicine

D-Index
95
Citations
42218
World Ranking
9924
National Ranking
5106

Overview

Steven E. Schild is a researcher affiliated with the Mayo Clinic in the United States whose work primarily spans the field of Medicine. Their research largely focuses on subfields within pulmonary and respiratory medicine, oncology, radiation, surgery, and radiology, nuclear medicine and imaging.

The scientist has contributed extensively to several main topics of study, which include:

  • Advanced Radiotherapy Techniques
  • Brain Metastases and Treatment
  • Radiation Therapy and Dosimetry
  • Glioma Diagnosis and Treatment
  • Management of metastatic bone disease
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies

Schild has published numerous papers with notable appearances in various scientific venues. Frequent publication outlets include:

  • Anticancer Research
  • International Journal of Radiation Oncology*Biology*Physics
  • In Vivo
  • Medical Physics
  • Cancers

Collaborations are a significant aspect of Schild's work, involving repeated partnerships with several co-authors, among them:

  • Dirk Rades
  • William W. Wong
  • Nathan Y. Yu
  • Carlos Vargas
  • Sameer R. Keole

Some of the recent papers associated with Steven E. Schild include:

  • Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology (2022), published in the Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021 (2021), published in the Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023 (2023), published in the Journal of the National Comprehensive Cancer Network
  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020), published in Radiotherapy and Oncology
  • Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617 (2021), published in Cancers

Best Publications

  • Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

    Julian R. Molina;Ping Yang;Stephen D. Cassivi;Steven E. Schild

  • Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

    Jeffrey D. Bradley;Rebecca Paulus;Ritsuko Komaki;Gregory Masters

  • Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

    David S. Ettinger;Douglas E. Wood;Dara L. Aisner;Wallace Akerley

  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

    David S. Ettinger;Douglas E. Wood;Charu Aggarwal;Dara L. Aisner

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    David S. Ettinger;David S. Ettinger;Douglas E. Wood;Douglas E. Wood;Dara L. Aisner;Wallace Akerley;Wallace Akerley

  • Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

    Stephen G. Chun;Chen Hu;Hak Choy;Ritsuko U. Komaki

  • Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

    Svetomir N. Markovic;Lori A. Erickson;Ravi D. Rao;Robert R. McWilliams

  • Malignant peripheral nerve sheath tumor: analysis of treatment outcome

    William W. Wong;Takanori Hirose;Bernd W. Scheithauer;Steven E. Schild

  • Non–Small Cell Lung Cancer, Version 6.2015

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines ® Insights: Non-Small Cell Lung Cancer, Version 4.2016 Featured Updates to the NCCN Guidelines

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

    David S. Ettinger;Dara L. Aisner;Douglas E. Wood;Wallace Akerley

  • Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis

    Alexander Sun;Kyounghwa Bae;Elizabeth M. Gore;Benjamin Movsas

  • Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

    Jeffrey D. Bradley;Chen Hu;Ritsuko R. Komaki;Gregory A. Masters

  • Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

    James R. Jett;Steven E. Schild;Kenneth A. Kesler;Gregory P. Kalemkerian

  • A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

    Gregory M.M. Videtic;Chen Hu;Anurag K. Singh;Joe Y. Chang

  • Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression

    Dirk Rades;Lukas J.A. Stalpers;Theo Veninga;Rainer Schulte

  • Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214

    Elizabeth M. Gore;Kyounghwa Bae;Stuart J. Wong;Alexander Sun

  • Prognostic Factors for Local Control and Survival After Radiotherapy of Metastatic Spinal Cord Compression

    Dirk Rades;Fabian Fehlauer;Rainer Schulte;Theo Veninga

  • The Outcome of Combined-Modality Therapy for Stage III Non-Small-Cell Lung Cancer in the Elderly

    Steven E. Schild;Philip J. Stella;Susan M. Geyer;James A. Bonner

  • Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

    Audrey Mauguen;Cécile Le Péchoux;Michele I. Saunders;Steven E. Schild

Frequent Co-Authors

Alex A. Adjei
Alex A. Adjei Cleveland Clinic
James R. Jett
James R. Jett Mayo Clinic
Peter Hoskin
Peter Hoskin University of Manchester
Everett E. Vokes
Everett E. Vokes University of Chicago
Robert L. Foote
Robert L. Foote Mayo Clinic
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Joe Y. Chang
Joe Y. Chang The University of Texas MD Anderson Cancer Center
Lucian R. Chirieac
Lucian R. Chirieac Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but want to explore broader healthcare careers or alternative pathways, there are several related online degrees to consider. For example, advanced nursing roles are in high demand across the United States. Many professionals are now opting for the fastest pmhnp program options, which help registered nurses quickly transition into psychiatric-mental health nurse practitioner roles to address ongoing mental health needs.

Administration and leadership opportunities are also expanding rapidly. For those more interested in the business side of healthcare, pursuing a healthcare administration degree cost analysis can help identify budget-friendly options. If you’re seeking graduate-level leadership roles, several affordable mha online programs are available, providing flexible and cost-effective paths to a Master of Healthcare Administration degree.

For those aiming for top clinical leadership positions, Doctor of Nursing Practice (DNP) degrees are a popular route. Students can find the most affordable dnp programs to advance their qualifications while keeping costs manageable. These online options offer flexible schedules, making them accessible to working professionals and career changers.

Best Scientists Citing Steven E. Schild

Trending Scientists

Recently Published Articles